ARCHIVES

Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever

October 31, 2014

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986

Degarelix Approved For Advanced Prostate Cancer

January 30, 2009

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000